Metabolic and nutritional aspects of Xylitol

Advances in Food Research

Volumn 25, Issue C, 1979, Pages 159-180

  Ylikahri, Reino ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; LIPID; XYLITOL;

ANIMAL; DIABETIC DIET; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOLYTIC ANEMIA; HUMAN; INTESTINE ABSORPTION; LIVER; METABOLISM; NUTRITION; REVIEW;

ANEMIA, HEMOLYTIC; ANIMAL; CARBOHYDRATES; DIABETIC DIET; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; INTESTINAL ABSORPTION; LIPIDS; LIVER; NUTRITION; XYLITOL;

EID: 0018620927     PISSN: 00652628     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2628(08)60237-2     Document Type: Article

References (74)

1. Ahnefeld, F.W., Halmágyi, M., Milewski, P., Glukose and Glukoseaustauschstoffe in der Infusions-therapie des operativen Bereiches. Ritzel, G., Brubacher, G., (eds.) “Monosaccharides and Polyalcohols in Nutrition, Therapy and Dietetics”, 1976, Huber, Bern, 242.
2. Arsenis, C., Touster, O., Nicotinamide adenine dinucleotide phosphate-linked xylitol dehydrogenase in guinea pig liver cytosol. J. Biol. Chem. 244 (1969), 3895–3899.
3. Asakura, T., Adachi, K., Minakami, S., Yoshikawa, H., Non-glycolytic sugar metabolism in human erythrocytes. I. Xylitol metabolism. J. Biochem. (Tokyo 62 (1967), 184–193.
4. Bässler, K.H., Adaptive processes corcemed with absorption and metabolism of xylitol. Horecker, B.L., Lang, K., Takagi, Y., (eds.) “International Symposium on Metabolism, Physiology, and Clinical Use of Pentoses and Pentitols”, 1969, Springer-Verlag, Berlin and New York, 190.
5. Bässler, K.H., Quantitative aspects of the metabolism of glucose, fructose, sorbitol and xylitol. Ritzel, G., Brubacher, G., (eds.) “Monosaccharides and Polyalcohols in Nutrition, Therapy and Dietetics”, 1976, Huber, Bern, 22.
6. Bässler, K.H., Dreiss, G., Antiketogene Wirkung von Xylit bei alloxandiabetischen Ratten. Klin. Wochenschr. 41 (1963), 593–595.
7. Bässler, K.H., Heesen, D., Die Bildung von Leber- und Muskelglykogen aus Xylit, Sorbit und Glucose bei gesunden und alloxandiabetischen Ratten. Klim. Wochenschr. 41 (1963), 595–598.
8. Bässler, K.H., Prellwitz, W., Unbehaun, V., Lang, K., Xylitstoffwechsel beim Menschen. Zur Frage der Eignung von Xylit als Zuckerersatz beim Diabetiker. Klin. Wochenschr. 40 (1962), 791–793.
9. Bässler, K.H., Stein, G., Belzer, W., Xylitstoffwechsel und Xylitresorption. Stoffwechseladaptation als Ursache für Resorptionsbeschleunigung. Biochem. Z. 346 (1966), 171–185.
10. Bässler, K.H., Fingerhut, M., Czok, G., Hemmung der Fettsäureoxydation als ein Faktor bei der antiketogenen Wirkung von Zuckern und Polyalkoholen. Klin. Wochenschr. 44 (1966), 899–900.
11. Batzinger, R.P., Ou, S.-Y.L., Bueding, E., Saccharin and other sweeteners: Mutagenic properties. Science 198 (1977), 944–946.
12. Brin, M., Miller, O.N., The safety of oral xylitol. Sipple, H.L., McNutt, K.W., (eds.) “Sugars in Nutrition”, 1974, Academic Press, New York, 591.
13. Burns, J.J., Biosynthesis of L-ascorbic acid; basic defect in scurvy. Am. J. Med. 26 (1959), 740–748.
14. Dubach, U.D., Feiner, E., Forgo, I., Orale Verträglichkeit von Xylit bei stoffwechselge-sunden Probanden. Schweiz. Med Wochenschr. 99 (1969), 190–194.
15. Förster, H., Comparative metabolism of xylitol, sorbitol and fructose. Sipple, H.L., McNutt, K.W., (eds.) “Sugars in Nutrition”, 1974, Academic Press, New York, 259.
16. Förster, H., Metabolism of glucose substitutes compared to that of glucose. Ritzel, G., Brubacher, G., (eds.) “Monosaccharides and Polyalcohols in Nutrition, Therapy and Dietetics”, 1976, Huber, Bern, 68.
17. Förster, H., Meyer, E., Zilge, M., Erhöhung von Serumharnsaure und Serumbilirubin nach hochdosierten Infusionen von Sorbit, Xylit und Fructose. Klin. Wochenschr. 48 (1970), 878–879.
18. Fritz, I.B., Factors influencing the rates of long-chain fatty acid oxidation and synthesis in mammalian systems. Physiol. Rev. 41 (1961), 52–129.
19. Froesch, E.R., Jakob, A., The metabolism of xylitol. Sipple, H.L., McNutt, K.W., (eds.) “Sugars in Nutrition”, 1974, Academic Press, New York, 241.
20. Froesch, E.R., Zapf, J., Keller, U., Oelz, O., Comparative study of the metabolism of U- 14C-fructose, U- 14C-sorbitol and 14C-xylitol in the normal and in the streptozotocindiabetic rat. Eur. J. Clin. Invest. 2 (1971), 8–14.
21. Geser, K.A., Förster, H., Pröls, H., Mehnert, H., Zur Frage einer Wirkung von Xylit auf die Insulinsekretion des Menschen. Klin. Wochenschr. 45 (1967), 851–852.
22. Goto, Y., Anzai, M., Chiba, M., Ohneda, A., Kawashima, S., Maruhama, Y., Clinical effects of xylitol on carbohydrate and lipid metabolism in diabetics. Lancet 2 (1965), 918–921.
23. Gupta, S.D., Chaudhuri, C.R., Chatterjee, I.B., Incapability of L-ascorbic acid synthesis by insects. Arch. Biochem. Biophys. 152 (1972), 890–899.
24. Hauschildt, S., Watts, R.W.E., Studies on the effect of xylitol on oxalate formation. Biochem. Pharmacol. 25 (1976), 27–29.
25. Hollmann, S., Touster, O., “Non-Glycolytic Pathways of Metabolism of Glucose”, 1964, Academic Press, New York, 107.
26. Horecker, B.L., Lang, K., Takagi, Y., (eds.) “International Symposium on Metabolism, Physiology and Clinical Use of Pentoses and Pentitols”, 1969, Springer-Verlag, Berlin and New York.
27. Huttunen, J.K., Serum lipids, uric acid and glucose during chronic consumption of fructose and xylitol in healthy human subjects. Ritzel, Brubacher, G., (eds.) “Monosaccharides and Polyalcohols in Nutrition, Therapy and Dietetics”, 1976, Huber, Bern, 105.
28. Jakob, A., Williamson, J.R., Asakura, T., Xylitol metabolism in perfused rat liver. J. Biol. Chem. 246 (1971), 7623–7631.
29. Keller, U., Froesch, E.R., Vergleichende Untersuchungen über den stoffwechsel von Xylit, Sorbit und Fructose beim Menschen. Schweiz. Med. Wochenschr. 102 (1972), 1017–1022.
30. Kosaka, K., Stimulation of insulin secretion by xylitol administration. Horecker, B.L., Lang, K., Takagi, Y., (eds.) “International Symposium on Metabolism, Physiology, and Clinical Use of Pentoses and Pentitols”, 1969, Springer-Verlag, Berlin and New York, 212.
31. Kuzuya, T., Some recent observations on xylitol-induced insulin secretion. Horecker, B.L., Lang, K., Takagi, Y., (eds.) “International Symposium on Metabolism, Physiology, and Clinical Use of Pentoses and Pentitols”, 1969, Springer-Verlag, Berlin and New York, 230.
32. Kuzuya, T., Kanazawa, Y., Kosaka, K., Stimulation of insulin secretion by xylitol in dogs. Endocrinology 84 (1969), 200–207.
33. Kuzuya, T., Kanazawa, Y., Hayashi, M., Kikuchi, M., Ide, T., Species difference in plasma insulin responses to intravenous xylitol in man and several mammals. Endocrinol. Jpn. 18 (1971), 309–320.
34. Lang, K., Xylit, Stoffwechsel und klinische Verwendung. Klin. Wochenschr. 49 (1971), 233–245.
35. McCormick, D.B., Touster, O., The conversion in vivo of xylitol to glycogen via the pentose phosphate pathway. J. Biol. Chem. 229 (1957), 451–461.
36. Mäenpää, P.H., Raivio, K.O., Kekomäki, M.P., Liver adenine nucleotides: Fructose-induced depletion and its effect on protein synthesis. Science 161 (1968), 1253–1254.
37. Mäkinen, K.K., Long-term tolerance of healthy human subjects to high amounts of xylitol and fructose: General and biochemical findings. Ritzel, G., Brubacher, G., (eds.) “Monosaccharides and Polyalcohols in Nutrition, Therapy and Dietetics”, 1976, Huber, Bern, 92.
38. Marks, P.A., Banks, J., Drug-induced hemolytic anaemias associated with glucose-6-phosphate dehydrogenase deficiency: A genetically heterogenous trait. Ann. N.Y. Acad. Sci. 128 (1965), 198–206.
39. Mehnert, H., Zuckeraustauschstoffe in der Diabetes-diaet. Ritzel, G., Brubacher, G., (eds.) “Monosaccharides and Polyalcohols in Nutrition, Therapy and Dietetics”, 1976, Huber, Bern, 295.
40. Mertz, D.P., Kaiser, V., Klöpfer-Zaar, M., Beisbarth, H., Serumkonzentrationen ver-schiedener Lipide und von Harnsäure während 2-wöchiger Verabreichung von Xylit. Klin. Wochenschr. 50 (1972), 1107–1111.
41. Ohnuki, M., Preventing effect of xylitol on suppression of adrenocortical function by steroid therapy. Horecker, B.L., Lang, K., Takagi, Y., (eds.) “International Symposium on Metabolism, Physiology, and Clinical Use of Pentoses and Pentitols”, 1969, Springer-Verlag, Berlin and New York, 334.
42. Opitz, K., The influence of xylitol and other polyols and sugars on fat mobilization. Horecker, B.L., Lang, K., Takagi, Y., (eds.) “International Symposium on Metabolism, Physiology, and Clinical Use of Pentoses and Pentitols”, 1969, Springer-Verlag, Berlin and New York, 238.
43. Paulini, K., Kristallablagerungen im Gewebe nach Infusionen im Rahmen einer Intensiv-therapie. Ritzel, G., Brubacher, G., (eds.) “Monosaccharides and Polyalcohols in Nutrition, Therapy and Dietetics”, 1976, Huber, Bern, 204.
44. Pelkonen, R., Ylikahri, R., Effect of dietary xylitol on glucose balance in insulin dependent diabetes, 1980 To be published.
45. Pesch, H.-J., Krampf, F.-D., Menzel, H., Weiland, H., Eidam, U.-W., Prestele, H., Heid, H., Zur Wirkung von Kohlenhydratinfusionen auf die Bildung von Calciumoxalat-Niederschlaegen in der Niere: Morphologische und biochemische Befunde bei Verstorbenen und im Tierversuch. Ritzel, G., Brubacher, G., (eds.) “Monosaccharides and Polyalcohols in Nutrition, Therapy and Dietetics”, 1976, Huber, Bern, 193.
46. Pitkänen, E., Sahlström, K., Determination of urinary polyalcohols by means of gas-liquid chromatography. Ann. Med. Exp. Biol. Fenn. 46 (1968), 151–157.
47. Ritzel, G., Brubacher, G., (eds.) “Monosaccharides and Polyalcohols in Nutrition, Therapy and Dietetics”, 1976, Huber, Bern.
48. Rofe, A.M., Thomas, D.W., Edwards, R.G., Edwards, J.B., [14C] oxalate synthesis from [U- 14C] xylitol. In vivo and in vitro studies. Biochem. Med. 18 (1977), 440–451.
49. Schumer, W., Adverse effects of xylitol in parenteral alimentation. Metab., Clin. Exp. 20 (1971), 345–347.
50. Seino, Y., Taminato, T., Inoue, Y., Goto, Y., Ikeda, M., Imura, H., Xylitol: Stimulation of insulin and inhibition of glucagon responses to arginine in man. J. Clin. Endocrinol. Metab. 42 (1976), 736–743.
51. Smith, M.G., Polyol dehydrogenase. 4. Crystallization of the L-iditol dehydrogenase of sheep liver. Biochem. J. 83 (1962), 135–144.
52. Thomas, D.W., Edwards, J.B., Gilligan, J.E., Lawrence, J.R., Edwards, R.G., Complications following intravenous administration of solutions containing xylitol. Med. J. Aust. 1 (1972), 1238–1246.
53. Thomas, D.W., Gilligan, J.E., Edwards, J.B., Edwards, R.G., Lactic acidosis and osmotic diuresis produced by xylitol infusion. Med. J. Aust. 1 (1972), 1246–1248.
54. Thomas, D.W., Edwards, J.B., Edwards, R.G., Toxicity of parenteral xylitol. Sipple, H.L., McNutt, K.W., (eds.) “Sugars in Nutrition”, 1974, Academic Press, New York, 567.
55. Thomas, D.W., Hannett, B., Chalmers, A., Rofe, A.M., Edwards, J.B., Edwards, R.G., Oxalate excretion during carbohydrate infusions. Ritzel, G., Brubacher, G., (eds.) “Monosaccharides and Polyalcohols in Nutrition, Therapy and Dietetics”, 1976, Huber, Bern, 181.
56. Toussaint, W., Roggenkamp, K., Bässler, K.H., Behandlung der Ketonämie im Kindersalter mit Xylit. Z. Kinderheilkd. 98 (1967), 146–154.
57. Touster, O., Essential pentosuria and the glucuronate-xylulose pathway. Fed. Proc., Fed. Am. Soc. Exp. Biol. 19 (1960), 977–983.
58. Touster, O., The uronic acid pathway and its defect in essential pentosuria. Horecker, B.L., Lang, K., Takagi, Y., (eds.) “International Symposium on Metabolism, Physiology, and Clinical Use of Pentoses and Pentitols”, 1969, Springer-Verlag, Berlin and New York, 79.
59. Touster, O., The metabolism of polyols. Sipple, H.L., McNutt, K.W., (eds.) “Sugars in Nutrition”, 1974, Academic Press, New York, 229.
60. Touster, O., Shaw, D.R., Biochemistry of acyclic polyols. Physiol. Rev. 42 (1962), 181–225.
61. Touster, O., Reynolds, V.H., Hutcheson, R.M., The reduction of L-xylulose to xylitol by guinea pig liver mitochondria. J. Biol. Chem. 221 (1956), 697–702.
62. Van Eys, J., Wang, Y.M., Chan, S., Tanphaichitr, V.S., King, S.M., Xylitol as a therapeutic agent in glucose-6-phosphate dehydrogenase deficiency. Sipple, H.L., McNutt, K.W., (eds.) “Sugars in Nutrition”, 1974, Academic Press, New York, 613.
63. Wang, Y.M., Van Eys, J., The enzymatic defect in essential pentosuria. N. Engl. J. Med. 282 (1970), 892–896.
64. Wang, Y.M., Patterson, J.H., Van Eys, J., The potential use of xylitol in glucoses-phosphate dehydrogenase deficiency. J. Clin. Invest. 50 (1971), 1421–1428.
65. Wang, Y.M., King, S.M., Patterson, J.H., Van Eys, J., Mechanism of xylitol toxicity in the rabbit. Metab., Clin. Exp. 22 (1973), 885–894.
66. Wilkinson, A.W., (eds.) “Parenteral Nutrition”, 1972, Williams & Wilkins, Baltimore, Maryland.
67. Williamson, J.R., Scholz, R., Browning, E.T., Control mechanisms of gluconeogenesis and ketogenesis. II. Interactions between fatty acid oxidation and the citric acid cycle in perfused rat liver. J. Biol. Chem. 244 (1969), 4617–4628.
68. Williamson, J.R., Scholz, R., Browning, E.T., Thurman, R.G., Fukami, M.H., Metabolic effects of ethanol in perfused rat liver. J. Biol. Chem. 244 (1969), 4617–4628.
69. Willimson, J.R., Scholz, R., Browning, E.T., Thurman, R.G., Fukami, M.H., Metabolie effects of ethanol in perfused rat liver. J. Biol. Chem. 244 (1969), 5044–5054.
70. Williamson, J.R., Jakob, A., Refino, C., Control of the removal of reducing equivalents from the cytosol in perfused rat liver. J. Biol. Chem. 246 (1971), 7632–7641.
71. Wilson, R.B., Martin, J.M., Plasma insulin concentrations in dogs and monkeys after xylitol, glucose or tolbutamide infusion. Diabetes 19 (1970), 17–22.
72. Woods, H.F., The metabolic complications of intravenous nutrition. Ritzel, G., Brubacher, G., (eds.) “Monosaccharides and Polyalcohols in Nutrition, Therapy and Dietetics”, 1976, Huber, Bern, 54.
73. Woods, H.F., Krebs, H.A., Xylitol metabolism in the isolated perfused rat liver. Biochem. J. 134 (1973), 437–443.
74. Ylikahri, R.H., Leino, T., Metabolic interactions of xylitol and ethanol in healthy males. Metab., Clin. Exp. 28 (1979), 25–29.